FIELD: medicine; pharmaceutics.
SUBSTANCE: present invention relates to pharmaceutics, gene therapy and medicine, specifically to pharmaceutical compositions of a recombinant non-enveloped virus, in particular, recombinant adeno-associated virus (rAAV), which can be used for treatment and prevention of various diseases.
EFFECT: compositions have high stability.
46 cl, 2 dwg, 22 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ISOLATED MODIFIED CAPSID PROTEIN VPI OF ADENO-ASSOCIATED VIRUS SEROTYPE 5 (AAV5), CAPSID AND VECTOR BASED THEREON | 2021 |
|
RU2820088C1 |
| ISOLATED MODIFIED VP1 CAPSID PROTEIN OF ADENO-ASSOCIATED VIRUS OF SEROTYPE 5 (AAV5), CAPSID AND VECTOR BASED ON IT | 2019 |
|
RU2751592C2 |
| METHODS FOR TREATMENT OF PHENYLKETONURIA | 2019 |
|
RU2788484C2 |
| ADENO-ASSOCIATED VIRUS VECTOR | 2015 |
|
RU2743382C2 |
| SCALABLE METHODS FOR OBTAINING RECOMBINANT VECTOR BASED ON ADENO-ASSOCIATED VIRUS (AAV) IN SYSTEM OF SERUM-FREE SUSPENSION CELL CULTURE, SUITABLE FOR CLINICAL USE | 2016 |
|
RU2766583C2 |
| METHOD FOR PRODUCING PARTICLES OF RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR (rAAV) | 2017 |
|
RU2768045C2 |
| COMPLETELY SCALABLE METHOD FOR PRODUCING rAAV BASED ON COLUMNS | 2017 |
|
RU2754467C2 |
| METHODS FOR ENHANCING BIOLOGICAL ACTIVITY OF RECOMBINANT ADENO ASSOCIATED VIRUS PRODUCED BY BACULOVIRUS SYSTEM | 2017 |
|
RU2762948C2 |
| METHODS AND COMPOSITIONS FOR TREATING AMYLOID DEPOSITS | 2013 |
|
RU2673484C2 |
| ADENO-ASSOCIATED VIRAL VECTORS FOR TREATMENT OF MYOCILIN (MYOC) GLAUCOMA | 2015 |
|
RU2746991C2 |
